Nasal Obstruction in Sleep Apnea Patients Compared to the General Population
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01282125 |
Recruitment Status
:
Completed
First Posted
: January 24, 2011
Last Update Posted
: March 13, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Recent clinical findings of research at Trondheim University Hospital suggest that surgical correction of the nose septum in addition to volume reduction of the nose cavity may be beneficial in patients who suffer from both nose obstruction and obstructive sleep apnea syndrome(data not yet published).
This study aims to compare nose obstruction prevalence in sleep apnea patients and the general population
Condition or disease |
---|
Obstructive Sleep Apnoea Syndrome Nasal Obstruction |
Study Type : | Observational |
Actual Enrollment : | 217 participants |
Observational Model: | Cohort |
Time Perspective: | Cross-Sectional |
Official Title: | A Comparative Study of Nasal Obstruction in a Sleep Apnea Population Compared to the General Population |
Actual Study Start Date : | December 2010 |
Actual Primary Completion Date : | November 2016 |
Actual Study Completion Date : | November 2016 |

Group/Cohort |
---|
sleep apnea
100 patients suffering from obstructive sleep apnea syndrome
|
controls
100 subjects matching cases to age, sex, and body weight
|
- patient reported nasal obstruction [ Time Frame: 1 week ]assessed by a 10-point visual analogue scale (VAS) and Sino Nasal Outcome Score(SNOT-20) questionnaire.
- objective nasal obstruction [ Time Frame: 1 week ]measured by acoustical rhinometry and Peak Nasal Inspiratory Flow (PNIF).

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 70 Years (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- ???
Exclusion Criteria:
- ???

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01282125
Norway | |
St Olavs Hospital Trondheim University Hospital | |
Trondheim, Norway, 7020 |
Principal Investigator: | Ståle S. Nordgård, MD PhD | Aleris/NTNU |
Publications of Results:
Responsible Party: | Norwegian University of Science and Technology |
ClinicalTrials.gov Identifier: | NCT01282125 History of Changes |
Other Study ID Numbers: |
OSAS og nasalstenose |
First Posted: | January 24, 2011 Key Record Dates |
Last Update Posted: | March 13, 2017 |
Last Verified: | March 2017 |
Studies a U.S. FDA-regulated Drug Product: | No | |
Studies a U.S. FDA-regulated Device Product: | No |
Keywords provided by Norwegian University of Science and Technology:
general population prevalence Norway |
Additional relevant MeSH terms:
Apnea Sleep Apnea Syndromes Sleep Apnea, Obstructive Nasal Obstruction Respiration Disorders Respiratory Tract Diseases Signs and Symptoms, Respiratory Signs and Symptoms |
Sleep Disorders, Intrinsic Dyssomnias Sleep Wake Disorders Nervous System Diseases Nose Diseases Airway Obstruction Respiratory Insufficiency Otorhinolaryngologic Diseases |